8-Modified CMP-Sialic Acid and Derivatives
A R T I C L E S
ses of ternary complexes in which both donor and acceptor
substrate (analogues) are bound.12 Sialic acids in extracellular
glycoconjugates are commonly found conjugated to lactose or
N-acetyl-lactosamine as shown in Figure 1.13 8′′-Modified sialyl
lactose derivatives were chosen as our synthetic targets because
the enzymes under study work well on lactose and aryl
lactosides are more readily prepared than the analogous N-acetyl
glucosamine-containing derivatives. The synthesis of such 8′′-
modified sialyl lactose derivatives could, in principle, be carried
out by chemical modification of sialyl lactose. However, the
complexity of the protecting-group chemistry required and the
presence of multiple functional groups would render such a route
challenging. A more promising alternative is a chemoenzymatic
approach in which a chemical modification of the 8-position
on the sialic acid monosaccharide is carried out first and then
enzymes are employed to transfer the modified sugar onto the
lactose moiety.
Despite the relevance of the 8-hydroxyl group of sialic acids
in biology, there have been few reports of chemical manipulation
of this position. Of these studies most have concentrated on
deoxygenation,14,15 sulfonation16 and simple alkylation,17,18 and
reports of halogenation at this position, with the exception of
iodination,19,20 are entirely absent. These syntheses utilize
lengthy reaction sequences to obtain a protected sialic acid
derivative with only OH8 free, which is further manipulated as
required. Lengthy reaction sequences have been necessary
because direct regioselective functionalization of OH8 is difficult
and thus multiple deprotection and reprotection steps have been
required to gain access to a sugar that has only OH8 free.21 We
present a relatively short reaction sequence, exploiting the
different chemical reactivities of each of the five hydroxyl
groups, to gain access to OH8 starting from a simple sialic acid
glycoside. This route allows the ready manipulation and
installation of multiple functionalities at this position.
relatively remote from the anomeric center, we were optimistic
that this approach could work. Similarly our experience with a
range of sialyltransferases gave us confidence that the CMP
derivatives so formed could act as substrates for at least one of
these enzymes. If successful, such an approach would not only
provide us access to our desired sialyl lactose analogues but
also provide further insights into the specificities of representa-
tives of the two classes of enzymes employed in their synthesis.
This manuscript describes the chemical synthesis of 8-deoxy,
8-deoxy-8-fluoro and 8-O-methyl analogues of sialic acid, as
well as a truncated heptose analogue of sialic acid in which C8
and C9 have been removed. It further describes the conversion
of each of these analogues to their activated CMP donor sugar
using a bacterial CMP-sialic acid synthetase and then use of
these derivatives as substrates for two different bacterial
sialyltransferases to prepare multimilligram quantities of each
modified sialyl lactose derivative. Insights into the specificities
of these two sialyltransferases, Cst-I from Campylobacter
jejuni25 and Pm0188h from Pasteurella multocida,26 were
provided by determination of kinetic parameters for transfer by
each enzyme.
Materials and Methods
All enzymes were obtained from the Sigma-Aldrich company,
with the exception of CMP-sialic acid synthetase,22 Cst-I27 and
Pm0118h,28 which were expressed and purified as previously
described.
The general method for synthesis of 8-modifed CMP-donor
sugars is as follows. Sialic acid analogue (1 equiv) and CTP
disodium salt (1.05 equiv) were dissolved in Tris buffer (100 mM,
pH 8.5) containing magnesium chloride (20 mM) and DTT (0.1
mM) to give a final sialic acid concentration of 15 mM. CMP-
sialic acid synthetase (1 U/µmol) and inorganic pyrophosphatase
(1 U/mmol) were added, and the mixture was tumbled at ambient
temperature. The pH of the solution was checked regularly, and
aqueous sodium hydroxide solution (1 M) was added as appropriate
to keep the pH constant. On completion of reaction, as observed
by TLC analysis (ethyl acetate/methanol/water/concd ammonia
solution in a 4:3:2:1 ratio mobile phase), the mixture was cooled
to -80 °C. Once it had thawed, it was filtered (0.44 µm) and
incubated with alkaline phosphatase (20 U/mmol) for 10 min. The
mixture was filtered (0.44 µm) again and loaded directly onto an
ion-exchange column, pre-equilibrated with ammonium formate (50
mM). After an initial wash, using the same buffer, a stepped gradient
(50 mM to 1 M) was performed, and products containing fractions
were identified by TLC, pooled, and lyophilized. This crude product
was dissolved in the minimum volume of buffer (20 mM am-
monium formate buffer, pH 8.1) and loaded onto a size exclusion
column. The column was run at 10 mL/h, and fractions were
collected every 15 min. Product-containing fractions were identified
by TLC analysis, pooled, and lyophilized.
Once the modified sialic acids are chemically synthesized,
the second step of this chemoenzymatic approach requires access
to two classes of enzymes that will, respectively, synthesize
the CMP-sialic acid derivatives (CMP-sialic acid synthetase)
and transfer the sialic acid (sialyltransferase). Because enzymes
are often rather specific for their substrates, this approach carries
the risk that the enzymes might well not function with such
modified species. However, previous studies have shown that
CMP-sialic acid synthetases can be remarkably tolerant to
substrate modification,22-24 and because the 8-position is
(12) Persson, K.; Ly, H. D.; Dieckelmann, M.; Wakarchuk, W. W.; Withers,
S. G.; Strynadka, N. C. J. Nat. Struct. Biol. 2001, 8, 166–175.
(13) Yu, R. K.; Bieberich, E.; Xia, T.; Zeng, G. C. J. Lipid Res. 2004, 45,
783–793.
(14) Miyazaki, T.; Sato, H.; Sakakibara, T.; Kajihara, Y. J. Am. Chem.
Soc. 2000, 122, 5678–5694.
All Michaelis-Menten kinetic parameters were determined using
a CMP release assay.29 Cst-I kinetics were performed at 37 °C in
HEPES pH 7.5 buffer (20 mM) containing sodium chloride (50
mM), manganese chloride (10 mM), and magnesium chloride (10
mM) at substrate concentrations from 0.1 to 2 mM. Pm0118h
(15) Zbiral, E.; Schreiner, E.; Salunkhe, M. M.; Schulz, G.; Kleineidam,
R. G.; Schauer, R. Liebigs Ann. Chem. 1989, 519–526.
(16) Tanaka, M.; Kai, T.; Sun, X. L.; Takayanagi, H.; Furuhata, K. Chem.
Pharm. Bull. (Tokyo) 1995, 43, 2095–2098.
(17) Dufner, G.; Schworer, R.; Muller, B.; Schmidt, R. R. Eur. J. Org.
Chem. 2000, 1467–1482.
(18) Hanashima, S.; Ishikawa, D.; Akai, S.; Sato, K.-i., Carbohydr. Res.
2009, 344, 747–752.
(25) Gilbert, M.; Brisson, J. R.; Karwaski, M. F.; Michniewicz, J.;
Cunningham, A. M.; Wu, Y. Y.; Young, N. M.; Wakarchuk, W. W.
J. Biol. Chem. 2000, 275, 3896–3906.
(19) Brandstetter, H. H.; Zbiral, E. Liebigs Ann. Chem. 1983, 2055–2065.
(20) Hasegawa, A.; Adachi, K.; Yoshida, M.; Kiso, M. Carbohydr. Res.
1992, 230, 257–272.
(26) Ni, L. S.; Chokhawala, H. A.; Cao, H. Z.; Henning, R.; Ng, L.; Huang,
S. S.; Yu, H.; Chen, X.; Fisher, A. J. Biochemistry 2007, 46, 6288–
6298.
(21) Hemeon, I.; Bennet, A. J. Synthesis 2007, 1899–1926.
(22) Karwaski, M. F.; Wakarchuk, W. W.; Gilbert, M. Protein Expression
Purif. 2002, 25, 237–240.
(27) Chiu, C. P. C.; Lairson, L. L.; Gilbert, M.; Wakarchuk, W. W.; Withers,
S. G.; Strynadka, N. C. J. Biochemistry 2007, 46, 7196–7204.
(28) Yu, H.; Chokhawala, H.; Karpel, R.; Yu, H.; Wu, B. Y.; Zhang, J. B.;
Zhang, Y. X.; Jia, Q.; Chen, X. J. Am. Chem. Soc. 2005, 127, 17618–
17619.
(23) Nahalka, J.; Patoprsty, V. Org. Biomol. Chem 2009, 7, 1778–1780.
(24) Mizanur, R. M.; Pohl, N. L. Appl. Microbiol. Biotechnol. 2008, 80,
757–765.
9
J. AM. CHEM. SOC. VOL. 132, NO. 27, 2010 9431